Patients in the US with the ultra-rare disease WHIM syndrome now have their first approved treatment, after X4 Pharma’s Xolremdi was given a green light by the FDA. Oral CXCR4 antagonist Xolremdi ...

A resource for reactor physicists and engineers and students of nuclear power engineering, this publication provides a comprehensive summary of the thermophysical properties data needed in nuclear ...

Abstract: Extremely large-scale multiple-input-multiple-output (XL-MIMO), which offers vast spatial degrees of freedom, has emerged as a potentially pivotal enabling technology for the sixth ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. Chart does not reflect ...